Strategic Partnerships Olio has recent and active collaboration momentum with health systems and providers across post-acute and SNF networks, including partnerships with Sterling Healthcare Management, ASCcare, AION Biosystems, Kno2, and Banner Health. This presents opportunities to align with enterprise care coordination programs and expand footprints in post-acute and behavioral health segments.

Platform Growth The company launched its platform in early 2026 and has since expanded feature sets across multiple facilities, signaling readiness for scale. Sales opportunities exist to upsell additional modules, integration capabilities, and expanded care journeys for larger provider networks and multi-site operators.

Tech Enablement Olio’s tech stack emphasizes interoperability and security (HIPAA compliance, PostgreSQL, Datadog, reCAPTCHA) with real-time record access via Kno2. This can be leveraged to position Olio as a compliant, cloud-native backbone for data-driven care coordination and seamless EHR interoperability for prospects prioritizing data integrity and patient safety.

Financial Signal With a revenue range of fifty to one hundred million and a recent Series B funding of eleven million, Olio demonstrates solid traction and capital availability to support expanded sales motions, onboarding of large health networks, and accelerated product development for care transitions and post-acute optimization.

Market Fit Customers and pilots span post-acute, SNF, and behavioral health networks, including banners and strategic health system partnerships. The focus on reducing costs and improving outcomes aligns with target buyer priorities—care coordinators, payer-agnostic providers, and health plans seeking efficient care journeys and early deterioration signals.